Patents by Inventor Eric C. Bartee

Eric C. Bartee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Myxoma-treated graft material for cancer treatment
    Patent number: 10322149
    Abstract: A method of treating or preventing graft versus host disease (GVHD) in a subject receiving a graft comprising hematopoietic cells is provided. The method comprises contacting the graft ex vivo with an amount of a Myxoma Virus effective to inhibit proliferation of T lymphocytes in the graft and to treat or prevent GVHD in the host subject following infusion of the graft into the subject. After the contacting of the graft with the Myxoma Virus, the method comprises transplanting the virus-treated graft into the subject.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: June 18, 2019
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Douglas G. McFadden, Eric C. Bartee, Christopher R. Cogle
  • Methods for Treating or Preventing Graft Versus Host Disease
    Publication number: 20180064760
    Abstract: A method of treating or preventing graft versus host disease (GVHD) in a subject receiving a graft comprising hematopoietic cells is provided. The method comprises contacting the graft ex vivo with an amount of a Myxoma Virus effective to inhibit proliferation of T lymphocytes in the graft and to treat or prevent GVHD in the host subject following infusion of the graft into the subject. After the contacting of the graft with the Myxoma Virus, the method comprises transplanting the virus-treated graft into the subject.
    Type: Application
    Filed: August 14, 2017
    Publication date: March 8, 2018
    Inventors: Douglas G. McFadden, Eric C. Bartee, Christopher R. Cogle
  • Method for treating or preventing graft versus host disease
    Patent number: 9730960
    Abstract: A method of treating or preventing graft versus host disease (GVHD) in a subject receiving a graft comprising hematopoietic cells is provided. The method comprises contacting the graft ex vivo with an amount of a Myxoma Virus effective to inhibit proliferation of T lymphocytes in the graft and to treat or prevent GVHD in the host subject following infusion of the graft into the subject. After the contacting of the graft with the Myxoma Virus, the method comprises transplanting the virus-treated graft into the subject.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: August 15, 2017
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Douglas G. McFadden, Eric C. Bartee, Christopher R. Cogle
  • Method for Treating or Preventing Graft Versus Host Disease
    Publication number: 20140328804
    Abstract: A method of treating or preventing graft versus host disease (GVHD) in a subject receiving a graft comprising hematopoietic cells is provided. The method comprises contacting the graft ex vivo with an amount of a Myxoma Virus effective to inhibit proliferation of T lymphocytes in the graft and to treat or prevent GVHD in the host subject following infusion of the graft into the subject. After the contacting of the graft with the Myxoma Virus, the method comprises transplanting the virus-treated graft into the subject.
    Type: Application
    Filed: June 11, 2012
    Publication date: November 6, 2014
    Applicant: University of Florida Research Foundation, Inc.
    Inventors: Douglas G. McFadden, Eric C. Bartee, Christopher R. Cogle